Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2

Jaishri O. Blakeley, D. Gareth Evans, John Adler, Derald Brackmann, Ruihong Chen, Rosalie E. Ferner, C. Oliver Hanemann, Gordon Harris, Susan M. Huson, Abraham Jacob, Michel Kalamarides, Matthias A. Karajannis, Bruce R. Korf, Victor Felix Mautner, Andrea I. Mcclatchey, Harry Miao, Scott R. Plotkin, William Slattery, Anat O. Stemmer-Rachamimov, D. Bradley WellingPatrick Y. Wen, Brigitte Widemann, Kim Hunter-Schaedle, Marco Giovannini

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Medicine and Dentistry

    Neuroscience